06. What is the optimal prophylaxis strategy (dosing, route of administration, frequency) in COVID-19+ patients?20200822215317
06. What is the optimal prophylaxis strategy (dosing, route of administration, frequency) in COVID-19+ patients?
Nineteen percent of protocols recommended standard pharmacologic VTE prophylaxis dosing for all COVID-19 patients regardless of estimated VTE risk. Te...
05. Which COVID-19+ patients should receive VTE prophylaxis?20200822215210
05. Which COVID-19+ patients should receive VTE prophylaxis?
Numerous studies have reported generally higher rates of VTE in inpatients with COVID-19 infection (even with VTE prophylaxis) than is typically seen ...
04. How should patients with or without CAC already on therapeutic anticoagulation be managed?20200822215053
04. How should patients with or without CAC already on therapeutic anticoagulation be managed?
The literature to date indicates that inpatients with COVID-19 infection appear to have a heightened risk of VTE as mentioned above.......
03. Should patients with CAC be treated, and if so, how?20200822214947
03. Should patients with CAC be treated, and if so, how?
The guidelines of institutions within the HOMERuN collaborative on the approach to treatment of CAC varied widely......
02. What labs should be ordered on admission, and how should these be followed?20200822214827
02. What labs should be ordered on admission, and how should these be followed?
Very little is known about the prognostic value of any specific laboratory. General consensus appears to be that a low D-dimer in patients with COVID-...
01. What is COVID-19–associated coagulopathy (CAC), and how does it compare to DIC?20200822195848
01. What is COVID-19–associated coagulopathy (CAC), and how does it compare to DIC?
71% of institutions referred to COVID-19–associated coagulopathy based on specific laboratory parameters and an increased risk for thrombosis. ...